Codetta Bio Welcomes Paul McEwan and Mitch Levine to Board
Portfolio - People | Dec 04, 2024 | Anzu Partners LLC
Codetta Bio, a leader in integrated multi-omics solutions, has appointed Paul McEwan and Mitch Levine as independent members of its Board of Directors. Both individuals bring significant experience in life sciences and investment strategy. McEwan is known for his entrepreneurship in life science tools with a history of successful exits, while Levine is an expert in corporate strategy and finance. Their appointments underscore Codetta Bio's commitment to advancing leadership in the multi-omics market, aiming to innovate in biomarker research and translational science.
Sectors
- Biotechnology
- Private Equity
Geography
- United States – Codetta Bio is based in Morrisville, North Carolina, indicating activity within the United States.
Industry
- Biotechnology – Codetta Bio operates within the biotechnology industry, focusing on multi-omics solutions and biomarker tools.
- Private Equity – Anzu Partners LLC, a private equity firm, supports Codetta Bio, highlighting activity within the private equity sector.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Codetta Bio | Target | Company | A leader in integrated multi-omics solutions, advancing biomarker measurement tools and translational research. |
| Anzu Partners LLC | PE Firm | Company | The private equity firm backing Codetta Bio. |
| Paul McEwan | Board Member | Person | Serial entrepreneur in life science tools, joining Codetta Bio's Board. |
| Mitch Levine | Board Member | Person | Strategic expert in corporate finance joining Codetta Bio's Board. |